Second Malignant Neoplasms in Patients Under 40 Years of Age With Laryngeal Cancer
Authors:
- 1 April 2001
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 111 (4) , 563-567
Abstract
Objectives/Hypothesis To determine the incidence of second malignant neoplasms (SMN) in patients under 40 years of age with invasive squamous cell carcinoma (SCC) of the larynx.Study Design Retrospective.Methods Using a National Cancer Institute tumor registry database encompassing 1973–1996, the incidence of SMN in patients under 40 years of age with laryngeal cancer was determined and compared with that of the registry's older, more traditional laryngeal cancer population. Median follow‐up was 136 months.Results Among the 364 patients under the age of 40 years with laryngeal cancer, 30 (8.2%) had developed a secondary malignancy to date. In comparison, 4876 (21.4%) of 22,786 patients 40 years or older with laryngeal cancer were affected by an SMN. Kaplan‐Meier analysis of the younger cohort projected 3.0%, 6.8%, and 10.7% relative risk of developing a SMN at any site over 5‐, 10‐, and 15‐year periods, respectively, after index tumor diagnosis. Similar results for the older cohort were 14.2%, 28.1%, and 39.4% at 5, 10, and 15 years, respectively. Further Kaplan‐Meier analysis demonstrated at least a fourfold increased risk for the development of secondary upper aerodigestive tract malignancies among older compared with younger patients.Conclusion Patients under 40 years of age with invasive SCC of the larynx are significantly less likely to develop a second malignancy than their older counterparts.Keywords
This publication has 20 references indexed in Scilit:
- Head and neck squamous cell carcinoma: Better to be youngOtolaryngology–Head and Neck Surgery, 2000
- Second malignant neoplasia in patients with T1 glottic cancer treated with radiationThe Laryngoscope, 1998
- Meta-Analysis of Second Malignant Tumors in Head and Neck Cancer: The Case for an Endoscopic Screening ProtocolAnnals of Otology, Rhinology & Laryngology, 1992
- Mutagen Sensitivity in Patients With Head and Neck Cancers: A Biologic Marker for Risk of Multiple Primary MalignanciesJNCI: Journal of the National Cancer Institute, 1990
- Young Adults With Head and Neck Cancer Express Increased Susceptibility to Mutagen-lnduced Chromosome DamageJAMA, 1989
- Second malignant tumors in patients with laryngeal carcinoma: Diagnosis, treatment, and preventionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- The implication of tobacco use in the young adult with head and neck cancerCancer, 1988
- Synchronous and metachronous tumours in patients with head and neck cancerThe Journal of Laryngology & Otology, 1983
- Second Primary Respiratory Tract Malignant Neoplasms in Supraglottic CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1981
- Analysis of relative survival and proportional mortalityComputers and Biomedical Research, 1974